Clinical Trials · NCT04555850
A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Enrollment
- 30
- Start date
- Jul 2018
- Locations
- 1 site, China
- Primary endpoint
- Maximum Tolerated Dose (MTD) .